Coronavirus (COVID-19)

Greater Than COVID

NEW VIDEOS EXPAND THE CONVERSATION: Pediatricians Answer Questions about Children and the COVID-19 Vaccines

THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines available to children 5 and older and the status of vaccines for younger children. Produced by KFF under its Greater Than COVID public information response, this campaign is presented with the American Academy of Pediatrics. The new videos join the expansive living video library featuring Black and Latinx health care workers answering common questions on the COVID vaccines (available in English and Spanish). YouTube/Google, Facebook, Twitter and Pinterest are supporting distribution.

Read More
Trackers & tools
  • State Data and Policy Actions to Address Coronavirus

    There have been over 3 million cases and 131,000 deaths due to COVID-19 in the U.S.  Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 39 states that have eased or lifted stay-at-home orders.

  • COVID-19 Coronavirus Tracker

    This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 11.8 million confirmed cases and 544,000 confirmed deaths worldwide.

  • COVID-19 and Related State Data

    Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospitalizations, vaccinations and mental illness.
coronavirus vaccine
  • KFF COVID-19 Vaccine Monitor: Media and Misinformation

    This report examines COVID-19 misinformation and finds that nearly eight in ten adults either believe or are unsure about at least one false statement about COVID-19 or the vaccines. It also examines the news and social media sources the public trusts for information on the virus, and the relationship between news sources and belief in misinformation.

  • Nearly 3 in 10 Parents of Children Ages 5-11 Say Their Child Will Get a Vaccine Right Away Once Able

    This report tracks the public’s COVID-19 vaccine intentions, including parents’ intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers’ experiences with and views toward employer vaccine mandates.

  • Views On The U.S. Role In Global Vaccine Distribution

    This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how information affects the public’s views.

  • U.S. International COVID-19 Vaccine Donations Tracker

    This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies.

testing and Treatment
  • Rapid Home Tests for COVID-19: Issues with Availability and Access in the U.S.

    In this brief, we examine the various interrelated factors that have contributed to rapid home test scarcity in the U.S. There are several interrelated factors that impact the availability of rapid home COVID-19 tests. These range from the regulatory environment to the supply chain to federal investment and messaging to affordability.

  • Most private insurers are no longer waiving cost-sharing for COVID-19 treatment

    This analysis finds nearly three quarters of the largest health plans in each state are no longer waiving enrollees’ cost-sharing requirements for COVID-19 treatment as of August 2021. Insurers largely waived those costs early in the pandemic, before safe and effetive vaccines were available.

  • Five Things to Know about the Cost of COVID-19 Testing and Treatment

    This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.

  • COVID-19 Test Prices and Payment Policy

    This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.

health and economic disparities

Browse the Latest from KFF

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.